EUVIMEDEUVIMED entdecken
Crossref

Patients with secondary acute myeloid leukemia undergoing allogeneic stem‐cell transplant have inferior outcomes than de novo acute myeloid leukemia regardless minimal residual disease level by flow cytometry

Claudia Núñez-Torrón Stock iD, Carlos Jiménez Chillón, Fernando Martín Moro iD, Juan Marquet Palomanes iD, Kyra Velázquez Kennedy, Miguel Piris Villaespesa, Ernesto Roldán Santiago, Eulalia Rodríguez Martín, Anabelle Chinea Rodríguez, Valentín García Gutiérrez, Gemma Moreno Jiménez, Javier López Jiménez und 1 weitere

Hematological Oncology · 2023

DOI: 10.1002/hon.3160 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hematological Oncology, 2023. Verfasst von Claudia Núñez-Torrón Stock und 12 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Hematología y Hemoterapia, Hospital Universitario Infanta Sofía, Madrid, Spain. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Leukemia, Myeloid, Acute, Neoplasms, Second Primary. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Secondary acute myeloid leukemia (s‐AML) patients have a poor prognosis and currently the only curative therapy is allogeneic stem‐cell transplant (HSCT). However, we do not yet know whether transplantation is sufficient to reverse the poor prognosis compared to de novo AML patients. We analyzed survival after HSCT comparing a cohort of 58 patients with s‐AML versus 52 de novo patients who were transplanted between 2012 and 2020. Patients with s‐AML had worse event‐free survival (EFS) ( p = 0.001) and overall survival (OS) ( p < 0.001) compared to de novo AML due to an increased risk of relapse ( p = 0.06) and non‐relapse mortality ( p = 0.03). The main difference in survival was observed in patients who achieved complete remission (CR) before HSCT (EFS p = 0.002 OS and

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationLeukemia, Myeloid, AcuteNeoplasms, Second PrimaryHumansNeoplasm, ResidualFlow CytometryTransplantation, HomologousPrognosisRetrospective Studies

Stichwörter der Autor:innen

acute myeloid leukemiaallogeneic bone marrow transplantationflow cytometryminimal residual diseasesecondary leukemia

Autor:innen und Institutionen

  • Departamento de Hematología y Hemoterapia, Hospital Universitario Infanta Sofía, Madrid, Spain.
  • Universidad Alcalá de Henares, Alcala de Henares, Spain.
  • Universidad Europea de Madrid, Madrid, Spain.
  • Departamento de Hematología y Hemoterapia, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Departamento de Inmunología, Hospital Universitario Ramón y Cajal, Madrid, Spain.

ORCID-Profile: Claudia Núñez-Torrón Stock, Fernando Martín Moro, Juan Marquet Palomanes

Zitieren

APA

Núñez-Torrón Stock, C., Jiménez Chillón, C., Martín Moro, F., Marquet Palomanes, J., Velázquez Kennedy, K., Piris Villaespesa, M., Roldán Santiago, E., Rodríguez Martín, E., Chinea Rodríguez, A., García Gutiérrez, V., Moreno Jiménez, G., López Jiménez, J., & Herrera Puente, P. (2023). Patients with secondary acute myeloid leukemia undergoing allogeneic stem‐cell transplant have inferior outcomes than de novo acute myeloid leukemia regardless minimal residual disease level by flow cytometry. Hematological Oncology. https://doi.org/10.1002/hon.3160

Vancouver

Núñez-Torrón Stock C, Jiménez Chillón C, Martín Moro F, Marquet Palomanes J, Velázquez Kennedy K, Piris Villaespesa M, et al. Patients with secondary acute myeloid leukemia undergoing allogeneic stem‐cell transplant have inferior outcomes than de novo acute myeloid leukemia regardless minimal residual disease level by flow cytometry. Hematological Oncology. 2023. doi:10.1002/hon.3160

BibTeX
@article{NezTorrnStock2023,
  author = {Núñez-Torrón Stock, Claudia and Jiménez Chillón, Carlos and Martín Moro, Fernando and Marquet Palomanes, Juan and Velázquez Kennedy, Kyra and Piris Villaespesa, Miguel and Roldán Santiago, Ernesto and Rodríguez Martín, Eulalia and Chinea Rodríguez, Anabelle and García Gutiérrez, Valentín and Moreno Jiménez, Gemma and López Jiménez, Javier and Herrera Puente, Pilar},
  title = {Patients with secondary acute myeloid leukemia undergoing allogeneic stem‐cell transplant have inferior outcomes than de novo acute myeloid leukemia regardless minimal residual disease level by flow cytometry},
  journal = {Hematological Oncology},
  year = {2023},
  doi = {10.1002/hon.3160}
}
Kostenlos starten →